Caitlin Murphy, DNP, FNP-BC, AOCNP

Use of a home-based electronic monitoring system for symptom reporting reduced ED visits among people receiving treatment for metastatic cancer, according to study findings.

SAN DIEGO — Insurers rejected one-third of new prescriptions for specialty oral anticancer medications ordered for patients with blood cancers, according to retrospective data presented at ASH Annual Meeting and Exposition. Patients with commercial insurance and Medicaid had prescriptions rejected more often than patients with Medicare.

A meta-analysis of patients who underwent chimeric antigen receptor T-cell therapy for advanced blood cancers showed low prevalence of cardiovascular adverse events.